299 related articles for article (PubMed ID: 17071600)
1. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.
Williams TM; Sotgia F; Lee H; Hassan G; Di Vizio D; Bonuccelli G; Capozza F; Mercier I; Rui H; Pestell RG; Lisanti MP
Am J Pathol; 2006 Nov; 169(5):1784-801. PubMed ID: 17071600
[TBL] [Abstract][Full Text] [Related]
2. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Jun; 279(23):24745-56. PubMed ID: 15044451
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
4. Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling.
Sotgia F; Schubert W; Pestell RG; Lisanti MP
Cancer Biol Ther; 2006 Mar; 5(3):292-7. PubMed ID: 16418573
[TBL] [Abstract][Full Text] [Related]
5. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness.
Sotgia F; Williams TM; Schubert W; Medina F; Minetti C; Pestell RG; Lisanti MP
Am J Pathol; 2006 Jan; 168(1):292-309. PubMed ID: 16400031
[TBL] [Abstract][Full Text] [Related]
8. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice.
Williams TM; Cheung MW; Park DS; Razani B; Cohen AW; Muller WJ; Di Vizio D; Chopra NG; Pestell RG; Lisanti MP
Mol Biol Cell; 2003 Mar; 14(3):1027-42. PubMed ID: 12631721
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
Bianco C; Strizzi L; Mancino M; Watanabe K; Gonzales M; Hamada S; Raafat A; Sahlah L; Chang C; Sotgia F; Normanno N; Lisanti M; Salomon DS
Am J Pathol; 2008 Feb; 172(2):345-57. PubMed ID: 18202186
[TBL] [Abstract][Full Text] [Related]
11. RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.
Wang X; Feng S; Zhang H; Wang Y; Cui Y; Wang Z; Liu J; Zou W
Mol Biol Rep; 2011 Feb; 38(2):761-8. PubMed ID: 20411337
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.
Sotgia F; Del Galdo F; Casimiro MC; Bonuccelli G; Mercier I; Whitaker-Menezes D; Daumer KM; Zhou J; Wang C; Katiyar S; Xu H; Bosco E; Quong AA; Aronow B; Witkiewicz AK; Minetti C; Frank PG; Jimenez SA; Knudsen ES; Pestell RG; Lisanti MP
Am J Pathol; 2009 Mar; 174(3):746-61. PubMed ID: 19234134
[TBL] [Abstract][Full Text] [Related]
13. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
14. Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation.
Yang G; Timme TL; Naruishi K; Fujita T; Fattah el MA; Cao G; Rajagopalan K; Troung LD; Thompson TC
Exp Mol Pathol; 2008 Apr; 84(2):131-40. PubMed ID: 18358473
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling.
Sotgia F; Williams TM; Cohen AW; Minetti C; Pestell RG; Lisanti MP
Cell Cycle; 2005 Dec; 4(12):1808-16. PubMed ID: 16294019
[TBL] [Abstract][Full Text] [Related]
16. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
17. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation.
Sotgia F; Casimiro MC; Bonuccelli G; Liu M; Whitaker-Menezes D; Er O; Daumer KM; Mercier I; Witkiewicz AK; Minetti C; Capozza F; Gormley M; Quong AA; Rui H; Frank PG; Milliman JN; Knudsen ES; Zhou J; Wang C; Pestell RG; Lisanti MP
Am J Pathol; 2009 Feb; 174(2):613-29. PubMed ID: 19164602
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.
Mercier I; Camacho J; Titchen K; Gonzales DM; Quann K; Bryant KG; Molchansky A; Milliman JN; Whitaker-Menezes D; Sotgia F; Jasmin JF; Schwarting R; Pestell RG; Blagosklonny MV; Lisanti MP
Am J Pathol; 2012 Jul; 181(1):278-93. PubMed ID: 22698676
[TBL] [Abstract][Full Text] [Related]
19. An ex vivo co-culture model system to evaluate stromal-epithelial interactions in breast cancer.
Salameh TS; Le TT; Nichols MB; Bauer E; Cheng J; Camarillo IG
Int J Cancer; 2013 Jan; 132(2):288-96. PubMed ID: 22696278
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction.
Hassan GS; Williams TM; Frank PG; Lisanti MP
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2393-401. PubMed ID: 16415072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
